News & Trends - Biotechnology
AusBiotech calls for cutting-edge topics for 2020 conference
AusBiotech is calling for session proposals and speakers for AusBiotech 2020, to be held in Melbourne, 28 – 30 October.
Compelling stories or presentations on new, innovative research, projects or approaches to industry development, and inspirational, cutting-edge session topics are sought for showcasing to a global biotech industry.
AusBiotech is seeking speakers who are forward-thinking, diverse, engaging and who drive meaningful discussion about the business of biotech. Thought-provoking session ideas should explore current trends, critical and emerging topics, breakthroughs, and stories from a range of areas that encourage creative conversations both locally and abroad.
The annual AusBiotech conference brings together more than 1,000 leading innovative thinkers and inventors across the Australian and international biotech sector.
Applications for sessions will close at 5.00 pm, 28 February 2020. Submit your proposal now.
AusBiotech is committed to diversity and inclusion, and submissions for panels will only be considered if they meet a balanced gender representation threshold.
News & Trends - Pharmaceuticals
Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer
Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]
MoreNews & Trends - Pharmaceuticals
Government seals deal with industry for rare cancer therapy
Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]
MoreNews & Trends - MedTech & Diagnostics
Abbott showcases leadless pacemaker system to local stakeholders
MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]
MoreNews & Trends - Pharmaceuticals
Australian scientists pivotal in new drug class from BMS
Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]
More